4951 - 5000 of 6255 Results
Title
Year
-
OPENTitle: Screening non-MAPT genes of the Chr17q21 H1 haplotype in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 78Issue #:Start Page: 138End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.07.022Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7686230Citation Count: 16
-
OPENTitle: Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteinsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 79Issue #:Start Page: 1End Page: 13Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.032Citation Count: 41
- Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons2018OPENTitle: Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine NeuronsJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 103Issue #: 6Start Page: 874End Page: 892Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.ajhg.2018.10.018Best OA location URL: http://www.cell.com/article/S0002929718303707/pdfCitation Count: 39
-
OPENTitle: Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestryJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1432End Page: 1438Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27059Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5656509Citation Count: 147
-
OPENTitle: Development of a Positron Emission Tomography Radiotracer for Imaging Elevated Levels of Superoxide in NeuroinflammationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 3Start Page: 578End Page: 586Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00385Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5865080Citation Count: 67
-
OPENTitle: No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 3Start Page: e16End Page: e16Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awx378Best OA location URL: https://academic.oup.com/brain/article-pdf/141/3/e16/25046297/awx378.pdfCitation Count: 8
-
OPENTitle: Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2Journal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2112712119Best OA location URL: https://research.rug.nl/en/publications/2dd21a81-bba8-4531-aab2-e50105663eadCitation Count: 44
-
OPENTitle: Is the MC1R variant p.R160W associated with Parkinson's?Journal Name: Annals of NeurologyPublisher: WileyVol: 79Issue #: 1Start Page: 159End Page: 161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24527Best OA location URL: http://doi.org/10.1002/ana.24527Citation Count: 18
-
OPENTitle: Neurophysics Assessment of the Muscle Bioenergy Generated by Transcranial Magnetic StimulationJournal Name: ResearchPublisher: American Association for the Advancement of Science (AAAS)Vol: 2019Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2019/7109535Best OA location URL: https://doi.org/10.1155/2019/7109535Citation Count: 1
- Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?2023OPENTitle: Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?Journal Name: Environment InternationalPublisher: Elsevier BVVol: 173Issue #:Start Page: 107852End Page: 107852Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.envint.2023.107852Best OA location URL: https://doi.org/10.1016/j.envint.2023.107852Citation Count: 1
-
OPENTitle: Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent ToxicityJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2018.00036Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2018.00036/pdfCitation Count: 92
-
OPENTitle: PFTK1 kinase regulates axogenesis during development via RhoA activationJournal Name: BMC BiologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12915-023-01732-wBest OA location URL: https://bmcbiol.biomedcentral.com/counter/pdf/10.1186/s12915-023-01732-wCitation Count: 2
-
OPENTitle: Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicityJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 137Issue #: 6Start Page: 939End Page: 960Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-019-01993-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-019-01993-2.pdfCitation Count: 76
-
OPENTitle: Regional volumetric change in Parkinson's disease with cognitive declineJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 373Issue #:Start Page: 88End Page: 94Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.jns.2016.12.030Best OA location URL: https://doi.org/10.1016/j.jns.2016.12.030Citation Count: 27
- Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages2022OPENTitle: Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophagesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00297-9Best OA location URL: https://www.nature.com/articles/s41531-022-00297-9.pdfCitation Count: 33
-
OPENTitle: Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model miceJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 10Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.201708184Best OA location URL: https://doi.org/10.15252/emmm.201708184Citation Count: 47
-
OPENTitle: CoolMPS: evaluation of antibody labeling based massively parallel non-coding RNA sequencingJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 49Issue #: 2Start Page: e10End Page: e10Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/nar/gkaa1122Best OA location URL: https://academic.oup.com/nar/article-pdf/49/2/e10/36084915/gkaa1122.pdfCitation Count: 14
-
OPENTitle: Changes in kynurenine pathway metabolism in Parkinson patients with L‐DOPA‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 142Issue #: 5Start Page: 756End Page: 766Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.14104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14104Citation Count: 102
- RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8A2018OPENTitle: RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8AJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2018.00417Best OA location URL: https://doi.org/10.3389/fnmol.2018.00417Citation Count: 43
-
OPENTitle: Antipsychotic drug efficacy correlates with the modulation of D1 rather than D2 receptor-expressing striatal projection neuronsJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 26Issue #: 8Start Page: 1417End Page: 1428Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-023-01390-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10842629Citation Count: 49
-
OPENTitle: Exploring the early drivers of pain in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-025-90678-wBest OA location URL: https://www.nature.com/articles/s41598-025-90678-w.pdfCitation Count: 0
-
OPENTitle: Disease progression models for dominantly-inherited Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 5Start Page: 1244End Page: 1246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awy089Best OA location URL: https://academic.oup.com/brain/article-pdf/141/5/1244/25083196/awy089.pdfCitation Count: 2
-
OPENTitle: Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 112Issue #:Start Page: 136End Page: 148Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2018.01.004Best OA location URL: https://repositorio.uchile.cl/handle/2250/167345Citation Count: 145
-
OPENTitle: Understanding what aspects of Parkinson’s disease matter most to patients and familiesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-024-71555-4Best OA location URL: https://doi.org/10.1038/s41598-024-71555-4Citation Count: 8
- A Comparative Study of High-Contrast Fluorescence Lifetime Probes for Imaging Amyloid in Tissue2021OPENTitle: A Comparative Study of High-Contrast Fluorescence Lifetime Probes for Imaging Amyloid in TissueJournal Name: The Journal of Physical Chemistry BPublisher: American Chemical Society (ACS)Vol: 125Issue #: 50Start Page: 13710End Page: 13717Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jpcb.1c07762Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7615715Citation Count: 6
-
OPENTitle: A prospective controlled study of a wearable rhythmic vibrotactile device for tremor in Parkinson’s diseaseJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 172Issue #:Start Page: 51End Page: 60Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.clinph.2025.02.255Best OA location URL: https://doi.org/10.1016/j.clinph.2025.02.255Citation Count: 2
- Regional gray matter changes and age predict individual treatment response in Parkinson's disease2018OPENTitle: Regional gray matter changes and age predict individual treatment response in Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 21Issue #:Start Page: 101636End Page: 101636Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2018.101636Best OA location URL: https://doi.org/10.1016/j.nicl.2018.101636Citation Count: 25
-
OPENTitle: Holocue: A Wearable Holographic Cueing Application for Alleviating Freezing of Gait in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.628388Best OA location URL: https://doi.org/10.3389/fneur.2021.628388Citation Count: 21
-
OPENTitle: Diffusion tensor subspace imaging of double diffusion–encoded MRI delineates small fibers and gray‐matter microstructure not visible with single encoding techniquesJournal Name: Magnetic Resonance in MedicinePublisher: WileyVol: 93Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mrm.30463Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11971496Citation Count: 0
-
OPENTitle: Integrating multimodal and multiscale connectivity blueprints of the human cerebral cortex in health and diseaseJournal Name: PLOS BiologyPublisher: Public Library of Science (PLoS)Vol: 21Issue #: 9Start Page: e3002314End Page: e3002314Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pbio.3002314Best OA location URL: https://doi.org/10.1371/journal.pbio.3002314Citation Count: 36
-
OPENTitle: Bundled Three-Dimensional Human Axon Tracts Derived from Brain OrganoidsJournal Name: iSciencePublisher: Elsevier BVVol: 21Issue #:Start Page: 57End Page: 67Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.isci.2019.10.004Best OA location URL: http://www.cell.com/article/S2589004219303839/pdfCitation Count: 51
-
OPENTitle: Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: Distribution, dose-response, and mechanisms of deliveryJournal Name: Journal of Controlled ReleasePublisher: Elsevier BVVol: 286Issue #:Start Page: 467End Page: 484Publication Date:Open Access(OA) Status: OPENLicense: other-oa, other-oaDOI - Digital Object Identifier: 10.1016/j.jconrel.2018.08.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7234798Citation Count: 87
-
OPENTitle: Independent Spanish Validation of the Unified Dyskinesia Rating ScaleJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 3Start Page: 213End Page: 218Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12065Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12065Citation Count: 8
-
OPENTitle: Profiling Parkinson’s disease cognitive phenotypes via resting-state magnetoencephalographyJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 127Issue #: 1Start Page: 279End Page: 289Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00316.2021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8782645Citation Count: 8
-
OPENTitle: Using a stable protein scaffold to display peptides that bind to alpha‐synuclein fibrilsJournal Name: Protein SciencePublisher: WileyVol: 34Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/pro.70150Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pro.70150Citation Count: 0
- Targeted sequencing of Parkinson’s disease loci genes highlights SYT11, FGF20 and other associations2020OPENTitle: Targeted sequencing of Parkinson’s disease loci genes highlights SYT11, FGF20 and other associationsJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 2Start Page: 462End Page: 472Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa401Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7940168Citation Count: 44
-
OPENTitle: Neuroimmunology of the Interleukins 13 and 4Journal Name: Brain SciencesPublisher: MDPI AGVol: 6Issue #: 2Start Page: 18End Page: 18Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci6020018Best OA location URL: https://www.mdpi.com/2076-3425/6/2/18/pdf?version=1465804812Citation Count: 102
-
OPENTitle: The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregationJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01256-wBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-021-01256-wCitation Count: 11
-
OPENTitle: Awake Testing during Deep Brain Stimulation Surgery Predicts Postoperative Stimulation Side Effect ThresholdsJournal Name: Brain SciencesPublisher: MDPI AGVol: 9Issue #: 2Start Page: 44End Page: 44Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci9020044Best OA location URL: https://www.mdpi.com/2076-3425/9/2/44/pdf?version=1550479268Citation Count: 13
-
OPENTitle: Altered sphingolipid function in Alzheimer's disease; a gene regulatory network approachJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 102Issue #:Start Page: 178End Page: 187Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.02.001Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.02.001Citation Count: 15
-
OPENTitle: Biologic targets of prescription medications and risk of neurodegenerative disease in United States Medicare beneficiariesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 18Issue #: 5Start Page: e0285011End Page: e0285011Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0285011Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0285011&type=printableCitation Count: 6
-
OPENTitle: TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s diseaseJournal Name: Journal of Experimental MedicinePublisher: Rockefeller University PressVol: 215Issue #: 9Start Page: 2247End Page: 2264Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1084/jem.20180484Best OA location URL: https://rupress.org/jem/article-pdf/215/9/2247/1171465/jem_20180484.pdfCitation Count: 65
-
OPENTitle: Binding of the Human 14-3-3 Isoforms to Distinct Sites in the Leucine-Rich Repeat Kinase 2Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00302Best OA location URL: https://doi.org/10.3389/fnins.2020.00302Citation Count: 56
-
OPENTitle: Systematic review and consensus conceptual model of meaningful symptoms and functional impacts in early Parkinson’s DiseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00907-2Best OA location URL: https://www.nature.com/articles/s41531-025-00907-2.pdfCitation Count: 1
-
OPENTitle: Theoretical Optimization of Stimulation Strategies for a Directionally Segmented Deep Brain Stimulation Electrode ArrayJournal Name: IEEE Transactions on Biomedical EngineeringPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 63Issue #: 2Start Page: 359End Page: 371Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/tbme.2015.2457873Best OA location URL: https://europepmc.org/articles/pmc4732574?pdf=renderCitation Count: 32
-
OPENTitle: Genome-wide screen reveals Rab12 GTPase as a critical activator of Parkinson’s disease-linked LRRK2 kinaseJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.87098Best OA location URL: https://doi.org/10.7554/elife.87098Citation Count: 40
-
OPENTitle: Alpha‐Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic FailureJournal Name: Annals of NeurologyPublisher: WileyVol: 89Issue #: 6Start Page: 1212End Page: 1220Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26089Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8168720Citation Count: 77
-
OPENTitle: Olfactory identification in LRRK 2 G2019S mutation carriers: a relevant marker?Journal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 1Issue #: 9Start Page: 670End Page: 678Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.95Best OA location URL: https://escholarship.org/content/qt1kq281tf/qt1kq281tf.pdfCitation Count: 39
-
OPENTitle: Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in MiceJournal Name: EBioMedicinePublisher: Elsevier BVVol: 29Issue #:Start Page: 13End Page: 22Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2018.01.035Best OA location URL: http://www.thelancet.com/article/S2352396418300392/pdfCitation Count: 28
-
OPENTitle: Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 9Start Page: 1229End Page: 1236Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26251Citation Count: 102